By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Source Precision Medicine, dba SourceMDx, said today that it has assigned all its assets to Joseph Finn of accounting firm Finn, Warnke & Gayton for liquidation.

Source MDx has gone out of business and its intellectual property and patents will be sold at a sealed bid sale on April 29 at noon. The liquidation is being conducted for the benefits of Source MDx's creditors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.